Skip to main content

Table 4 Table of estimated absorbed doses to lungs and tumors from 3D and 3Dcomp reconstructions

From: Dosimetric impact of 3D motion-compensated SPECT reconstruction for SIRT planning

Number of patients

Lungs dose Gy (3D)

Lungs dose Gy (3Dcomp)

PDD of lungs (%)

Tumor dose Gy (3D)

Tumor dose Gy (3Dcomp)

PDD of Tumor (%)

1

9.2

9.4

1.9

179.3

180.4

0.6

245.0

NA

242.4

NA

− 1.1

NA

2

4.4

4.1

− 6.4

3

1.3

1.1

− 17.2

NA

NA

NA

4

1.3

1.4

2.6

NA

NA

NA

5

1.5

1.7

17.4

NA

NA

NA

6

1.1

1.2

8.4

NA

NA

NA

7

2.2

2.5

10.3

331.4

354.0

6.8

8

2.5

3.0

21.2

NA

NA

NA

9

0.3

0.3

4.0

186.2

184.4

− 1.0

10

8.3

4.3

− 48.6

229.3

284.1

23.9

147.8

166.1

12.4

91.5

71.5

− 21.8

175.6

155.0

− 11.7

118.7

84.2

− 29.0

11

0.7

0.7

9.7

76.0

73.1

− 3.7

12

4.8

2.1

− 56.9

NA

NA

NA

13

   

49.3

49.9

1.2

3.6

3.7

2.9

103.2

109.5

6.1

   

105.1

104.8

− 0.3

14

0.6

0.8

28.2

NA

NA

NA

15

3.0

4.2

39.4

170.6

164.5

− 3.6

16

1.4

1.7

20.1

148.4

148.6

0.2

16

0.4

0.5

17.2

NA

NA

NA

17

4.1

3.4

− 17.7

49.0

48.1

− 1.9

17

3.2

3.4

6.0

NA

NA

NA

18

4.4

3.5

− 20.3

88.4

72.0

− 18.6

19

8.1

8.8

8.8

190.3

186.7

− 1.8

20

1.3

1.6

29.8

73.2

69.4

− 5.1

116.1

116.1

− 0.02

21

0.2

0.2

6.8

NA

NA

NA

22

2.4

2.7

11.0

182.0

183.2

0.7

23

8.3

8.9

6.4

41.3

40.8

− 1.2

24

3.9

4.1

3.7

173.3

175.3

1.2

25

1.8

1.1

− 41.1

157.4

158.9

0.9

26

6.5

3.7

− 43.3

297.5

354.8

19.2

258.6

12.5

258.4

11.1

− 0.1

− 11.3

27

2.7

3.0

10.0

114.1

111.0

− 2.7

49.2

166.1

49.9

164.1

1.5

− 1.2

28

2.5

2.0

− 20.4

76.4

73.9

− 3.3

29

1.9

2.4

26.2

152.7

154.4

1.1

116.4

116.4

− 0.01

  1. For each patient and volume, the PDDs were also calculated
  2. NA tumor contours are not available